Αποτελέσματα Αναζήτησης
We continue to forge partnerships that are built on trust and accountability. Curium's focus is to develop, manufacture and supply world-class nuclear medicine products to customers around the globe. Find out who we are.
25 Νοε 2019 · CapVest, which specializes in mid-market buyouts, has hired JPMorgan and Rothschild to find a new owner for the Paris-based firm which makes nuclear tracers used in diagnostic imaging ...
Curium's management team is focused on developing Curium into a global leader in nuclear medicine with an emphasis on service and new product development.
Curium is the world’s leading nuclear medicine company. Discover more about our background, our purpose and our values. What we do. How we work. Worldwide offices. With a global reach, Curium services customers in over 60 countries. See where we operate and find a local office. Management team.
Owner. Director, Executive Human Resources, Management, Medical & Science. 3 emails found 1 phone number found. View contacts for Curium Pharma to access new leads and connect with decision-makers. View All Contacts. Details. Industries. Pharmaceutical. Headquarters Regions European Union (EU), Europe, Middle East, and Africa (EMEA)
9 Ιαν 2020 · CVC Capital Partners, Bain Capital, Clayton Dubilier & Rice, Nordic Capital and PAI Partners have submitted first-round bids to acquire Curium Pharma from CapVest in a deal that would value the company at $3 billion or more, according to Bloomberg.
See insights on Curium including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
